First Tracks Biotherapeutics, Inc.
TRAX
$15.97
$0.221.40%
NASDAQ
| 03/31/2026 | |||||
|---|---|---|---|---|---|
| Net Income | -6.97% | ||||
| Total Depreciation and Amortization | -79.37% | ||||
| Total Amortization of Deferred Charges | -- | ||||
| Total Other Non-Cash Items | 89.09% | ||||
| Change in Net Operating Assets | 240.22% | ||||
| Cash from Operations | 27.65% | ||||
| Capital Expenditure | 51.43% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | 135.18% | ||||
| Cash from Investing | 135.62% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -- | ||||
| Issuance of Common Stock | 37.35% | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 37.35% | ||||
| Foreign Exchange rate Adjustments | -- | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | 142.03% | ||||